Q32 Bio Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $42.1M | $211.7M | $108.4M |
| FY2022 | $50.5M | $228.5M | $34.0M |
| FY2023 | $118.5M | $47.1M | $25.6M |
| FY2024 | $86.7M | $92.3M | $78.0M |
| FY2025 | $19.8M | $61.8M | $48.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $42.1M | $211.7M | $108.4M |
| FY2022 | $50.5M | $228.5M | $34.0M |
| FY2023 | $118.5M | $47.1M | $25.6M |
| FY2024 | $86.7M | $92.3M | $78.0M |
| FY2025 | $19.8M | $61.8M | $48.3M |